[3-(aminomethyl)-3-methylpyrrolidin-1-yl]-[2-(2,4-dimethylphenyl)quinolin-4-yl]methanone;dihydrochloride
C24H29Cl2N3O — CID 120804488
Data last refreshed: (MolForge compound catalog, from PubChem)
About [3-(aminomethyl)-3-methylpyrrolidin-1-yl]-[2-(2,4-dimethylphenyl)quinolin-4-yl]methanone;dihydrochloride
[3-(aminomethyl)-3-methylpyrrolidin-1-yl]-[2-(2,4-dimethylphenyl)quinolin-4-yl]methanone;dihydrochloride (PubChem CID 120804488) has the molecular formula C24H29Cl2N3O and a molecular weight of 446.42 g/mol. Its IUPAC name is [3-(aminomethyl)-3-methylpyrrolidin-1-yl]-[2-(2,4-dimethylphenyl)quinolin-4-yl]methanone;dihydrochloride.
Molecular Properties
| Compound Name | [3-(aminomethyl)-3-methylpyrrolidin-1-yl]-[2-(2,4-dimethylphenyl)quinolin-4-yl]methanone;dihydrochloride |
|---|---|
| PubChem CID | 120804488 |
| Molecular Formula | C24H29Cl2N3O |
| Molecular Weight | 446.42 g/mol |
| Exact Mass | 445.17 |
| IUPAC Name | [3-(aminomethyl)-3-methylpyrrolidin-1-yl]-[2-(2,4-dimethylphenyl)quinolin-4-yl]methanone;dihydrochloride |
| SMILES | Cc1ccc(-c2cc(C(=O)N3CCC(C)(CN)C3)c3ccccc3n2)c(C)c1.Cl.Cl |
| InChI | InChI=1S/C24H27N3O.2ClH/c1-16-8-9-18(17(2)12-16)22-13-20(19-6-4-5-7-21(19)26-22)23(28)27-11-10-24(3,14-25)15-27;;/h4-9,12-13H,10-11,14-15,25H2,1-3H3;2*1H |
| InChIKey | NNJHJPXYGKSQJN-UHFFFAOYSA-N |
| XLogP | 5.17 |
| TPSA | 59.22 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 446.42 |
| LogP ≤ 5 | 5.17 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 3 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 120804488 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.